Agoracom Blog Home

Author Archive

VIDEO – AI/ML Innovations $AIML $AIMLF set to Make Waves w/ Health Gauge Partnership, U.S. Launch for AI Rx $PFM.ca $DM.ca $ADK.ca

Posted by AGORACOM-AB at 3:09 PM on Tuesday, October 26th, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Heal, a France-based global provider of proprietary digital mental health and wellness products.

In late September, AI/ML announced that it had completed its transaction to acquire a significant interest in Tech2Heal (dba Tech2Health), and that Tech2Heal was readying its remote patient monitoring platform for deployment.

Now, AI/ML Innovations & Tech2Heal’s AI Rx joint venture is preparing for imminent launch into the U.S. market, with a basket of wellness and health-tech products and services designed to improve an individual’s mental health and well-being, and utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center.

We caught up with Tim Daniels, AI/ML’s Executive Chairman, to discuss the firm’s progress…

VIDEO – TAAT Global Alternatives $TAAT $TOBAF “Beyond Tobacco” Eyes $10m Investment Boost, Preps Branded Apparel for Q1 2022 $MO $PM $BATS

Posted by AGORACOM-AB at 9:23 AM on Monday, October 18th, 2021

To understand the value proposition of TAAT, you first have to understand some recent massive trends in the Consumer Packaged Goods (CPG) space:

  • Non-alcoholic beer has grown to an $18bn USD market
  • The plant-based meat market is projected to hit $74bn USD By 2027

What they have in common is providing consumers of the original products with the exact same experience (taste, smell, etc.) without the negative parts of the original products.

TAAT has developed a nicotine-free and tobacco-free smoking experience known as TAAT™, which already launched in the USA. TAAT™ Beyond Tobacco™ cigarettes mimic those experiences without nicotine or tobacco.

Engineered to closely emulate the sensory components to provide the closest experience of smoking a tobacco cigarette – a product that tastes and smells just like tobacco – but without the nicotine.

October has seen a flurry of news for the company: 

OCT 5: The company reported Q3 2021 Financial Results:

1. Gross revenue grew to an all-time high of $1,305,358 in Q3 2021, an increase of 1,956% YOY
2. Gross profit for Q3 2021 was $781,226 with a gross profit margin of 59.84%
3. Healthy balance sheet with $10,174,001 in working capital

OCT 6: TAAT Announced it Would Be Releasing A Branded Merchandise Line of Apparel and Accessories in Q1 2022

OCT 13: TAAT Announced A Follow-On Private Placement for CAD $10m

We sat down with CEO Setti Coscarella for a company update…

VIDEO – Delic Corp $DELC $DELCF Aims to Become “Largest Psychedelic Wellness Chain in the U.S.” via Ketamine Wellness Centers Acquisition $CMPS $ALID

Posted by AGORACOM-AB at 1:43 PM on Friday, September 24th, 2021

How much is the market for psychedelics going to be worth?

According to one report published earlier this year by Data Bridge Market Research, it will reach $6.9 billion by 2027. Another report, from Research and Markets, predicts it will go further, reaching $10.75 billion by 2027.

In addition: California legislators are considering decriminalizing possession and sharing of psychedelics for adults 21 and older.

That’s the market context you need to know for Delic Corp, which bills itself as a marketplace for the mainstream to access psychedelic wellness.

Delic owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms, including:

  • Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology
  • MeetDelic, the premiere psychedelic wellness event, which takes place in Las Vegas this year in November
  • and Ketamine Infusion Centers, one of the largest ketamine clinics in the United States

In May, Delic acquired Complex Biotech Discovery Ventures (CBDV), a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development, for $7m USD, changing its name to Delic Labs.

In June, Delic paid $3m USD to acquire Ketamine Infusion Centers, a limited liability corporation formed under the laws of Arizona, which owns and operates ketamine infusion treatment clinics in Phoenix, Arizona and in Bakersfield, California.

And now, Delic has this month entered into a binding merger with Ketamine Wellness Centers (KWC) Arizona, which operates 10 ketamine infusion treatment clinics across the U.S., in Arizona, Colorado, Florida, Illinois, Minnesota, Nevada Texas and Washington.

The deal and the national presence will bring psychedelic wellness treatment to the masses, and makes Delic the largest psychedelic wellness chain in the United States.

  • Retail Footprint to Include 12 Open Locations, with 15 Additional Clinics in Development
  • Ensures Accessibility to Millions with Affordable Treatments and Insurance Coverage
  • KWC has been operating profitably and expanding significantly with 2020 revenues in excess of $3.5m USD, on track for $4.5m USD in 2021
  • Joining Ketamine Infusion Centers (acquired June, 2021), which has grown steadily with revenues in excess of $4.2m USD since 2019

We sat down with Matt Stang, Delic’s CEO, to delve further into the acquisition…

VIDEO – GameOn Entertainment Technologies $GET $GMETF Preps for Big Q4 w/ Cricket Partnerships, NFL Survivor Pool

Posted by AGORACOM-AB at 10:47 AM on Thursday, September 9th, 2021

GameOn Entertainment Technologies (CSE: GET) (OTC: GMETF) powers the best content in the world with the most innovative predictive gaming technologies by providing broadcasters, TV networks, OTT platforms, leagues, tournaments and sportsbooks with interactive, social experiences around sports, television and live events.

The company lets fans connect, make predictions, track live scores and be rewarded during every moment of their favorite sports, TV shows and live events, offering a solution for the future of superfan engagement.

Two of the firm’s most recent deals have made waves in the world of international cricket. After securing Indian giant MX Player as a partner in June, GameOn this month struck a deal with North American cricket coverage provider Willow TV.

The free-to-play games will be available to MX Player and Willow TV’s large and diverse fan bases for global cricket events, tournaments and leagues, and both products will go live to more than 280 million monthly viewers in October, in time for the ICC T20 World Cup.  

The partnerships are just two initiatives ahead of what is expected to be a major Q4. GameOn has also launched an NFL Shareholder Survivor Pool tournament, which is free to play for shareholders, partners and friends of the business.

Throughout the contest, competitors will learn more about the people behind the company, with prizes including rare NFTs and an all-inclusive trip to an NFL game with GameOn CEO Matt Bailey.

Partners can sign up here: https://www.runyourpool.com/join/pool_info.cfm?id=166248&p=gameon

Off the back of a strong week of trading, we sat down for a conversation with the chief executive – you won’t want to miss it!

VIDEO – TAAT Global Alternatives $TAAT $TOBAF “Beyond Tobacco” Offering Faces Rapid U.S., Int’l Expansion, After Strong Q2 Numbers $MO $PM $BATS

Posted by AGORACOM-AB at 3:49 PM on Friday, September 3rd, 2021

To understand the value proposition of TAAT, you first have to understand some recent massive trends in the Consumer Packaged Goods (CPG) space:

  • Non-alcoholic beer has grown to $18bn USD market
  • the plant-based meat market is projected to hit $74bn USD By 2027

What they have in common is providing consumers of the original products with the exact same experience (taste, smell, etc.) without the negative parts of the original products.

TAAT has developed a nicotine-free and tobacco-free smoking experience known as TAAT™, which already launched in the USA. TAAT™ Beyond Tobacco™ cigarettes mimic those experiences without nicotine or tobacco.

Engineered to closely emulate the sensory components to provide the closest experience of smoking a tobacco cigarette – a product that tastes and smells just like tobacco – but without the nicotine.

Last week the company passed two major milestones:

  • On August 25, TAAT announced that a Michigan tobacco chain would be placing TAAT in all 147 of its store locations
  • Two days later, TAAT announced that it had secured distribution on its third continent, with a purchase order for €360,000 (approximately $536,000 CAD) for a full shipping container of TAAT™ to be distributed in Australia

We sat down with CEO Setti Coscarella to break down the company’s rapid expansion, and examine what comes next…

VIDEO – Victory Square Technologies $VST $VSQTF Sees Record 6th Consecutive Quarter of Positive Net Income, Eyes Dividends, Tokens & Growth Industries $YDX.ca $SEV.ca $DBO.ca

Posted by AGORACOM-AB at 1:28 PM on Friday, September 3rd, 2021
Victory Square Technologies VST

Victory Square Technologies (VST:CSE / VSQTF:OTC / 6F6:FWB) builds, acquires and invests in promising start-ups, then provides the senior leadership and resources needed for fast-track growth.

Across its portfolio of 24 global companies, it covers A.I., Virtual Reality / Augmented Reality, Blockchain, Fintech, Health-tech, Gaming, Sports Betting and SaaS.

And the success its portfolio has achieved – by way of firms such as GameOn Entertainment TechnologiesHydreight and Immersive Tech – has led to a record sixth consecutive quarter with positive net income and earnings per share:

  • The firm reported record net income of $19,733,031 and positive Earnings Per Share of $0.30 in Fiscal 2020
  • During the six months ending June 30, 2021, the adjusted net income of the Company was $7,653,255
  • During the three months ending June 30, 2021, the adjusted net income of the Company was $2,222,180
  • VST Issued a special dividend of common shares of its portfolio company GameOn Entertainment Technologies (GET: CSE) in May 2021
  • Followed by a special dividend of common shares of its portfolio company Fantasy 360 Technologies Inc. (CSE (reserved):VRAR) aka Immersive Tech in August

We sat down with Shafin Diamond Tejani, Victory Square’s CEO, to break down the numbers and look ahead to the future…

VIDEO – VSBLTY Groupe Technologies $VSBY $VSBGF Rides “Deployment Momentum” to Strong Q2, w/ 165% Growth & $4.1m in New Sales $AT $MARK

Posted by AGORACOM-AB at 10:24 AM on Thursday, August 26th, 2021
VSBLTY

VSBLTY Groupe Technologies (CSE:VSBY / OTC:VSBGF) is a disruptive computer vision software company that is using A.I. and Machine Learning to transform the retail and security industries.

  • $VSBY Teaches Computers How to Interpret Surroundings. For example, detecting anomalies better than any human ever can
  • $VSBY Then Delivers the Context of Their Surroundings via Alerts, so that humans can make decisions and act on then faster than ever possible
  • $VSBY technology serves the dual function of both monitoring (i.e. a stadium, a store) and marketing (serving ads based on real-time demographics)

In March, the company signed a major deal with Grupo Modelo (part of the AB InBev family of companies) and Retailigent to jointly create an international digital in-store media network.

And in June, VSBLTY raised $9.78 million in funding, putting the company on a path to profitability.

Now, VSBLTY CEO Jay Hutton has provided a corporate update, detailing that:

  • Q2 yielded strong billings growth, at 165% over Q1
  • A total of $4.1 million USD in new contracts
  • And accelerated growth, as the company gains “deployment momentum.”

We sat down with the chief executive, for a deeper dive into the state of play…

VIDEO – Cardiol Therapeutics $CRDL Sees Accelerated Growth with NASDAQ Uplisting & Continued COVID-19 Threat $LXRX $MESO $HGEN $TYNA

Posted by AGORACOM-AB at 12:15 PM on Monday, August 16th, 2021

Biotech companies, by their very nature, can often be difficult to understand for investors… but in order to understand Cardiol, all you have to know is that the firm is developing therapies for heart disease and heart failure through cannabidiols.  

Cardiol Therapeutics is a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).

  • The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™.
  • CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically producedmanufactured under cGMP and THC free. (less than 10 ppm)

Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.

This week, the company passed another major milestone, moving from the OTC Markets to a U.S. listing on NASDAQ, under the symbol $CRDL – the same as its TSX symbol.

And with the COVID-19 Delta Variant running rampant through North America, Cardiol’s work has become more important than ever.

We sat down with David Elsley, Cardiol Therapeutics’ President & CEO, to discuss the uplisting…

VIDEO – AI/ML Innovations $AIML $AIMLF taps Tech2Health to expand in Digital Mental Health & Wellness Market $PFM.ca $DM.ca $ADK.ca

Posted by AGORACOM-AB at 2:31 PM on Wednesday, July 28th, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Health, a France-based global provider of proprietary digital mental health and wellness products.

Earlier this month, Tech2Health announced that it had entered into commercial contracts with three companies to provide digital mental health services to their employees and insured members. Based on the number of individuals covered and standard industry usage rates, Tech2Health estimates that these contracts may potentially generate an aggregate total of US$5 million of revenue over the 3-year life of the contracts.

AI/ML has a binding Letter of Intent to acquire a 70% undivided interest in the North American rights to Tech2Health’s complete portfolio of products and brands, in addition to a 22.22% equity interest in Tech2Health’s global operations.

We caught up with Tim Daniels, AI/ML’s Executive Chairman, for an overview of the partnership…

VIDEO – HealthSpace Data Systems $HS.ca $HDSLF Aims to Redefine Government Efficiency with Explosive Growth & New Contracts

Posted by AGORACOM-AB at 2:26 PM on Saturday, July 10th, 2021
HealthSpace HS 300 x 300

If there is one thing we know about governments – whether it’s at the local, state, or federal level – it is that they can be hugely inefficient.

HealthSpace Data Systems’ (CSE: HS) (OTCQB: HDSLF) (Frankfurt: 38H) “empowering government efficiency” solution has led the firm to become an industry leading tech pioneer, providing both enterprise- and mobile internet-based applications to more than 500 state and local government organizations in North America, including in California, Missouri, Illinois, Wisconsin and Ontario.

In April, HealthSpace launched GovCall, a teleconferencing platform focused exclusively on the government market. The company now offers the only integrated product suite that incorporates inspection, administration and analytics across all platforms in North America.

  • cloud-based and mobile platform helps revolutionize every aspect of government regulatory work
  • including licensing and inspections, accounting, even disease surveillance

The company continues to go from strength to strength. Last month, CEO Silas Garrison presented a sizable corporate update, outlining:

  • a strong start to the year: US$3.8M in new deals in Q1 2021 and US$5.6M in deals since the year’s start
  • Anticipate achieving US$8M in ARR under contract within the next 6-9 months.
  • This past December $HS raised more than CAD$6M million in equity. 
  • Will be used to deal with more aggressive R&D and feature development strategies, as well as handle the increasing volume of customers
  • $HS has doubled the number of team members over the last 9 months, with over 30 new hires, and has 74 full-time team members today
  • Paul Victor joined as our Head of Engineering in March
  • Chirag Bhatt joined the team in May as Director of Regulatory Affairs for Environmental Health. 
  • The total pipeline of deals stands at over US$22M, expected to close over the next 12-18 months.
  • Since last corporate update in Nov 2020, $HS has converted approximately US$7.3m of the pipeline to either signed or contract awards. 
  • Annualized, this is an 80% conversion rate from the pipeline (contract numbers, not by dollars).  As of today, the pipeline represents the addition of US$6.8M in new deals added to the pipeline in 2021.
  • The deals in this pipeline are of all sizes, ranging from US$9,000 to over US$5m.

We sat down with him to talk through the company’s progress and look ahead to 2022 and beyond.